Eli Lilly publishes trial results for next generation weight loss drug
Final phase trial data for retatrutide showed substantial weight reduction alongside health improvements in blood pressure and glucose levels. The multi receptor treatment outperformed existing medications, raising questions for clinicians about ideal patient dosing strategies.
